# EDGAR Filing Document

**Accession Number:** 0001388320
**File Stem:** 0001213900-25-106708
**Filing Date:** 2025-11
**Character Count:** 1252
**Document Hash:** d2c252c6f2136b26af8d36923157d038
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-106708.hdr.sgml**: 20251105

**ACCESSION NUMBER**: 0001213900-25-106708

**CONFORMED SUBMISSION TYPE**: ARS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20241231

**FILED AS OF DATE**: 20251105

**DATE AS OF CHANGE**: 20251105

**EFFECTIVENESS DATE**: 20251105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Actinium Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001388320
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 880378336
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** ARS
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36374
- **FILM NUMBER:** 251454985

**BUSINESS ADDRESS:**
- **STREET 1:** 100 PARK AVE., 23RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** (646) 677-3870

**MAIL ADDRESS:**
- **STREET 1:** 100 PARK AVE., 23RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cactus Ventures, Inc.
- **DATE OF NAME CHANGE:** 20070130

### Attached PDF Documents

**Attachment 1:** `ea0260530-03.pdf`

_No text found in this document._